Astellas Pharma

Daripada Wikipedia, ensiklopedia bebas.
Jump to navigation Jump to search
Astellas Pharma Inc.
Awam (K.K)
Didagangkan sebagai
ISINJP3942400007 Edit this on Wikidata
IndustriFarmaseutikal
PendahuluYamanouchi Pharmaceutical
Fujisawa Pharmaceutical
(Bergabung pada 2005)
Ditubuhkan1 April 2005; 15 tahun yang lalu (2005-04-01)
Ibu pejabat2-5-1, Nihonbashi-Honcho, Chūō-ku, Tokyo 103-8411, Jepun
Perancang utama
Yoshihiko Hatanaka
(Presiden dan CEO)
Keluaran
Hasil AS$11.06 bilion (FY 2013)

AS$1.28 bilion (

¥1,139 bilion
) (FY 2013)
Jumlah aset$14.86 bilion (2016)[1]
Bilangan pekerja
17,217 (2016)[2]
Anak syarikatAstellas US
Laman sesawangTapak web rasmi
Nota kaki / rujukan
[3][4][5]

Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) ialah syarikat farmaseutikal Jepun, ditubuhkan pada 1 April 2005 dari penggabungan Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) dan Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社, Fujisawa Yakuhin Kōgyō Kabushiki-gaisha).

Astellas ialah ahli Mitsubishi UFJ Financial Group (MUFJ) keiretsu.

Bacaan lanjut[sunting | sunting sumber]

  • "One step ahead of manufacturers' tricky footwork". The Chemist and Druggist (Opinion). Kent, England: CMP Information Ltd. 264 (6520): 15. 12 November 2005 – melalui Internet Archive. Manufacturers have, in the past, talked up the importance of bioequivalence to encourage prescribing of their brand.... Astellas is now conveniently ignoring that argument as it attempts to extend the life of Flomax beyond its patent expiry in February 2006.
  • "Ridaura Tiltab to cease". The Chemist and Druggist (News brief). Kent, England: CMP Medica. 2721 (6715): 6. 12 September 2009 – melalui Internet Archive.

Rujukan[sunting | sunting sumber]

  1. ^ "Astellas Pharma on the Forbes Global 2000 List". Forbes.com. Dicapai pada 13 August 2018.
  2. ^ "Corporate Information - Astellas Pharma Inc. GLOBAL WEBSITE". Astellas.com. Dicapai pada 13 August 2018.
  3. ^ "Corporate Profile". Astellas Pharma. Dicapai pada September 9, 2014.
  4. ^ "Annual Report 2014" (PDF). Astellas Pharma. Dicapai pada September 9, 2014.
  5. ^ "Astellas Pharma Snapshot". Bloomberg Businessweek. Dicapai pada January 25, 2015.

Pautan luar[sunting | sunting sumber]